骨髄の薬剤障害に対する骨髄輸血 (移殖) の免疫血液学的研究 第1報

Eight patients were described who suffered from bone-marrow failure due to Mitomycin treatment for cancer. Seven of them were treated with bone-marrow transfusion from their families.Investigations and observations were made on clinical, hematologic, immunohematologic and pathologic aspects of bone-marrow transfusion, but the purpose of this paper is only to report cases in which bone-marrow transfusion resulted in the immunohematological procedure and the blood group picture.Antibodies for donor's red cells were not detected in the sera of eight recipients, and donor-type red cells were not found in the blood of seven patients.There obtained evidence for a “take” of the homologous bonemarrow in case No. 2.